NextGen Healthcare, Inc. Common Stock
NXGN
NXGN was delisted on the 8th of November, 2023.
212 hedge funds and large institutions have $949M invested in NextGen Healthcare, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 68 increasing their positions, 75 reducing their positions, and 15 closing their positions.
233% more call options, than puts
Call options by funds: $50K | Put options by funds: $15K
180% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 15
13% more funds holding
Funds holding: 187 → 212 (+25)
7% more capital invested
Capital invested by funds: $884M → $949M (+$65.3M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$27.9M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$26.1M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$8.68M |
| 4 |
Two Sigma Investments
New York
|
+$4.61M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$25.9M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$9.78M |
| 3 |
Lazard Asset Management
New York
|
-$5.86M |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.05M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$2.89M |
NXGN Hedge Fund Activity: Q4 2022 in Review
212 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NextGen Healthcare, Inc. Common Stock (NXGN) for Q4 2022, worth a combined $949M — up 7.4% from $884M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NXGN positions and 15 closed out — a net gain of 27 holders — while 68 added to existing stakes and 75 trimmed.
The largest buyer was Millennium Management, adding an estimated $27.9M. The largest seller was JP Morgan Chase, cutting an estimated $25.9M.
- 212 institutional investors held NextGen Healthcare, Inc. Common Stock (NXGN) as of Q4 2022, up from 187 in Q3 2022.
- Funds reported $949M of NextGen Healthcare, Inc. Common Stock stock for Q4 2022, up 7.4% quarter-over-quarter.
- 42 funds opened new NextGen Healthcare, Inc. Common Stock positions in Q4 2022 and 15 closed out, a net change of +27 holders.
- The largest NextGen Healthcare, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $27.9M added.
- The largest NextGen Healthcare, Inc. Common Stock seller in Q4 2022 was JP Morgan Chase, an estimated $25.9M sold.
Based on aggregated 13F filings for Q4 2022.